- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02810847
The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years (I-BiT Plus)
Around one child in fifty has a lazy eye (termed amblyopia) where the eye is structurally normal but the vision fails to develop correctly. Around half of these children also have a squint (strabismus) where each eye has a different direction of gaze. This condition is the commonest cause of visual impairment in one eye in children.
This is a randomised control trial of wearing glasses alone (which will result in some visual improvement, termed refractive adaptation) and wearing glasses combined with using I-BiT Plus.
The hypothesis is that using I-BiT Plus will result in an improved visual outcome.
Study Overview
Detailed Description
This study will treat amblyopia (lazy eye) using 3-D computer technology and active shutter glasses. Computer games and DVD's are viewed through the active shutter glasses and are specially prepared to preferentially stimulate the lazy eye; the child can only play the games accurately if they are using their lazy eye. The study is funded by the NIHR and will be undertaken as a randomised control trial to compare this against normal computer games and DVD viewing combined with continuing refractive adaptation (a process that is known to occur for up to 30 weeks). Patients will receive 6 weeks of treatment (recommended 30 mins minimum of play time per day for 6 weeks in the treatment arm) and level of vision will be assessed after 6 weeks and the visual improvement (they will be wearing glasses and also undergoing refractive adaptation) compared with the control. Patients will return to standard care after the trial period which, at 6 weeks, should not affect the final visual outcome in a negative way. The participants will be recruited from patients currently attending one of the 4 trial sites and will have a diagnosis of amblyopia, and be aged between 3 years 6 months and 9 years 11 months. Current treatments for amblyopia include wearing an eye patch over the good eye for up to 6 hours per day, or using eye drops to blur the image in the good eye for periods of 4 weeks at a time. The aim is both to avoid the need for patching or penalisation (which are unpopular treatments) and to get an improved visual outcome.
Assessment study: A study on 62 patients where the investigators will compare the visual acuity, angle of strabismus, stereoacuity and depth of suppression as estimated by I-BiT against measurements made at orthoptic assessment. This data will help interpret the results of the randomised controlled trial and help direct future development.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rebecca Brown
- Phone Number: 67150 0115 9249924
- Email: Rebecca.brown4@nuh.nhs.uk
Study Contact Backup
- Name: Natalie McGregor, PhD
- Phone Number: 01159709049
- Email: researchsponsor@nuh.nhs.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The child must be aged between 3 years 6 months and 9 years 11 months (upper limit is one day before their 10th birthday on day of consent.)
- Visual acuity difference of at least 0.3 log units, with the amblyopic eye being 0.3 logMAR or worse.
- Must have undergone a minimum of 12 weeks refractive adaptation.
- Those in group one must not have had patching or penalisation at all previously but the other two groups' participants may have had previous occlusion.
- Must not have had previous strabismus surgery (for groups one and two, and for group three, they must start the treatment within 4 weeks of having surgery.
- Must be able to use the I-BiT plus system.
Exclusion Criteria:
- Stimulus deprivation amblyopia.
- Other ocular or neurological disease affecting the visual system (including Down's syndrome, developmental delay,Craniofacial syndrome,Foetal Alcohol Syndrome, and cerebral palsy among other conditions).
- Photosensitive epilepsy.
- Parent, guardian or child not prepared to give consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: I-BiT Plus
6 weeks of I-Bit treatment plus (at least 30 mins/day, 6 days/week)
|
The study will treat amblyopia (lazy eye) using 3-D computer technology and active shutter glasses.
Computer games and DVD's are viewed through the active shutter glasses and are specially prepared to preferentially stimulate the lazy eye; the child can only play the game accurately if they are using their lazy eye.
|
No Intervention: Control
Refractive adaption or observation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The change of visual acuity from baseline to week six post randomisation visit between the two arms in each group.
Time Frame: 6 weeks
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Successful delivery and installation of equipment to patients' homes, and any reasons for failure
Time Frame: 10 weeks
|
10 weeks
|
The ability of the patients to use the equipment in their home (unsupervised) setting and any reasons why not. Ocular alignment Stereoacuity Proportion of patients completing course
Time Frame: 10 weeks
|
10 weeks
|
The time taken by the patients to use the equipment in their home (unsupervised) setting.
Time Frame: 10 weeks
|
10 weeks
|
The robustness of the equipment by measuring failure / breakage rate.
Time Frame: 10 weeks
|
10 weeks
|
Completeness of outcome measures will be assessed via the frequency of missing data.
Time Frame: 10 weeks
|
10 weeks
|
The recruitment rate and reasons for not taking part.
Time Frame: 10 weeks
|
10 weeks
|
The retention rate and reasons for drop out.
Time Frame: 10 weeks
|
10 weeks
|
Any problems encountered with the randomisation process.
Time Frame: 10 weeks
|
10 weeks
|
The standard deviation in visual acuity at 6 weeks; this will inform sample size calculations for a future trial to assess effectiveness of the I-BiT™ system.
Time Frame: 6 weeks
|
6 weeks
|
Change in visual acuity in the amblyopic eye from baseline to weeks 3 and 10 post randomisation between the two arms.
Time Frame: 8 Weeks
|
8 Weeks
|
Change in stereoacuity from baseline to week 3 post randomisation between the two arms.
Time Frame: 3 weeks
|
3 weeks
|
Change in stereoacuity from week 3 to weeks 6 and 10 for the I-BiT treated groups.
Time Frame: 8 Weeks
|
8 Weeks
|
Change in binocular status and ocular alignment from baseline to week 6 post randomisation between the two arms in each group.
Time Frame: 6 Weeks
|
6 Weeks
|
Change in binocular status and ocular alignment from week 6 to week 10 for the I-BiT treated groups.
Time Frame: 5 weeks
|
5 weeks
|
Quality of life questionnaire at week 6.
Time Frame: 6 weeks
|
6 weeks
|
Proportion of patients completing course of treatment (defined as minimum of 18 hours in total, which equates to 30 minutes per day 6 days per week for six weeks).
Time Frame: 18 hours
|
18 hours
|
The change in visual acuity, and angle of strabismus between weeks 3, 6 and 10 for the I-BiT treated groups.
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexander JE Foss, DM FRCOphth MRCP, Nottingham University Hospitals Nhs Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13OY006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Strabismus
-
University of MiamiCompletedSuture Strabismus SurgeryUnited States
-
Universidad Autonoma de MadridActive, not recruiting
-
Assiut UniversityNot yet recruitingLarge Angle Horizontal StrabismusEgypt
-
South Valley UniversityEnrolling by invitation
-
Minia UniversityCompleted
-
Universidad Autonoma de MadridCompleted
-
Shahid Beheshti University of Medical SciencesUnknownHorizontal Strabismus With High AC/A RatioIran, Islamic Republic of
-
Sun Yat-sen UniversityRecruitingStrabismus | Exotropia | Esotropia | Vertical StrabismusChina
-
Tanta UniversityCompletedSurgical Procedure, Unspecified | Ocular Discomfort | Strabismus, Divergent
Clinical Trials on I-Bit plus
-
CEU San Pablo UniversityUnknownUpper Extremity Paresis | Family | Infantile Hemiplegia | Constraint Induced Movement Therapy | Bimanual Intensive TherapySpain
-
M.D. Anderson Cancer CenterCLL Global Research FoundationRecruitingChronic Lymphocytic LeukemiaUnited States
-
Seoul National University HospitalRecruitingHypertension | Obstructive Sleep Apnea | Prehypertension | Blood Pressure | Essential Hypertension | Systolic Hypertension | Diastolic HypertensionKorea, Republic of
-
Sky LabsCompletedHealthyKorea, Republic of
-
Sky LabsCompletedHypertension | Blood Pressure | HypotensionKorea, Republic of
-
NorthShore University HealthSystemActive, not recruiting
-
University GhentUniversity Hospital, Ghent; Universitair Ziekenhuis Brussel; Vrije Universiteit... and other collaboratorsCompletedChronic Low Back Pain | Chronic Neck Pain | Insomnia ChronicBelgium
-
New York State Psychiatric InstituteCompleted
-
University of SalamancaCompleted